Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine
- 22 November 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (10), 1545-1552
- https://doi.org/10.1016/s0006-2952(96)00556-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor,Biochemistry, 1996
- Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerationsCancer, 1993
- Inhibition of the multidrug resistance efflux pumpBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.Journal of Clinical Oncology, 1992
- P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding siteBiochemical and Biophysical Research Communications, 1992
- Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADMCancer, 1991
- Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastineBiochemical and Biophysical Research Communications, 1988
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 1985
- On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drugBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984